Simplex Trading
TMCI icon

Simplex Trading’s Treace Medical Concepts TMCI Stock Holding History

Simplex Trading’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,929
Closed -$51.7K – 10162
2025
Q4 		$63.5K Buy
+25,929
New +$113K ﹤0.01% 5439
2025
Q1 		– Sell
-64,117
Closed -$576K – 9687
2024
Q4 		$477K Buy
64,117
+61,458
+2,311% +$411K ﹤0.01% 3591
2024
Q3 		$15K Sell
2,659
-33,821
-93% -$217K ﹤0.01% 6919
2024
Q2 		$242K Sell
36,480
-7,467
-17% -$60.3K ﹤0.01% 4472
2024
Q1 		$573K Sell
43,947
-23,403
-35% -$312K ﹤0.01% 3724
2023
Q4 		$858K Buy
67,350
+66,559
+8,415% +$672K ﹤0.01% 3148
2023
Q3 		$10K Buy
791
+664
+523% +$12.2K ﹤0.01% 7199
2023
Q2 		$3K Buy
+127
New +$3.28K ﹤0.01% 8293

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TMCI Position: Q1 2026 in Review

Simplex Trading sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 25,929 shares — an estimated $51.7K sold.

Simplex Trading first reported a position in TMCI in Q2 2023 and held it in 8 quarters. The position peaked at $858K in Q4 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Simplex Trading reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 25,929 Treace Medical Concepts shares in Q1 2026, an estimated $51.7K.
  • Simplex Trading first reported a position in Treace Medical Concepts in Q2 2023 and held it in 8 quarters.
  • Simplex Trading's Treace Medical Concepts position peaked at $858K in Q4 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.